Leju Finance Deng RufeiOn December 12, it was reported that Beijing Hehua Ruibo Technology Co., Ltd. (hereinafter referred to as "Hehua Ruibo") was registered with the Beijing Securities Regulatory Bureau yesterday, and the counseling agency was CITIC ** shares
According to the official website, Hehua Ruibo is a medical technology innovator and medical value creator, focusing on the R&D and manufacturing of surgical robots and the construction of intelligent surgical management platforms, providing medical institutions with intelligent orthopedic solutions. The products continue to cover the knee, hip, spine and other fields, providing multi-modal, digital preoperative planning information and high-precision and automated intraoperative registration and execution plans for clinics.
Founded on January 26, 2018, the legal representative is Li Shugang, with a registered capital of 50 million yuan, and its business scope is technology development, technology promotion, technology transfer, technical consultation, and technical services (except for human stem cells, genetic diagnosis and technology development and application). The company's major shareholder is Li Shugang, holding 3337%。At present, the company has 6 foreign investment enterprises, including Beijing and Huaruibo Medical Technology***. Li Shugang is the chairman, director and general manager of Hehua Ruibo.
According to Hehua Ruibo's report for the third quarter of 2023, Hehua Ruibo's operating income in the first three quarters of 2023 was 725660,000 yuan, net profit attributable to shareholders of the listed company -7276520,000 yuan, a year-on-year decrease of 1392%。